Tag: Mark Griffiths

Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis announces its major investments of around CHF 15...

Dishman’s subsidiary, Carbogen Amcis AG, pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today a joint funding agreement...

This function has been disabled for HealthTekPak.

error: Content is protected !!